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ABSTRACT
Members of the Cas family of focal adhesion proteins contain a highly
conserved C-terminal focal adhesion targeting (FAT) domain. To
determine the role of the FAT domain in these proteins, we compared
wild-type exogenous NEDD9 with a hybrid construct in which the
NEDD9 FAT domain had been exchanged for the p130Cas (also
known as BCAR1) FAT domain. Fluorescence recovery after
photobleaching (FRAP) revealed significantly slowed exchange of
the fusion protein at focal adhesions and significantly slower two-
dimensional migration. No differences were detected in cell stiffness
as measured using atomic force microscopy (AFM) and in cell
adhesion forcesmeasured with amagnetic tweezer device. Thus, the
slowed migration was not due to changes in cell stiffness or adhesion
strength. Analysis of cell migration on surfaces of increasing rigidity
revealed a striking reduction of cell motility in cells expressing the
p130Cas FAT domain. The p130Cas FAT domain induced rigidity-
dependent phosphorylation of tyrosine residues within NEDD9. This
in turn reduced post-translational cleavage of NEDD9, whichwe show
inhibits NEDD9-induced migration. Collectively, our data therefore
suggest that the p130Cas FAT domain uniquely confers a
mechanosensing function.
KEY WORDS: Focal adhesion, Mechanosensing, NEDD9, P130Cas,
FAT, Cell migration
INTRODUCTION
Focal adhesions sense biochemical and mechanical features of the
extracellular environment and transmit this information to the cell.
The Cas-family proteins NEDD9 (also known as HEF1 and Cas-L)
and p130Cas (also known as BCAR1) are examples of signalling
proteins that are recruited to focal adhesions, where they regulate
cell migration signals (Cary et al., 1998; Klemke et al., 1998;
Fashena et al., 2002; Natarajan et al., 2006; Meenderink et al., 2010;
Kong et al., 2011; Baquiran et al., 2013; Bradbury et al., 2014).
Both proteins contain a C-terminal focal adhesion targeting (FAT)
domain (Arold et al., 2002; Mace et al., 2011), characterised by
extensive primary sequence and tertiary structural similarity. The
identification of the FAT domain module in functionally
diverse focal adhesion-associated proteins (Arold et al., 2002;
Schmalzigaug et al., 2007; Garron et al., 2009; Mace et al., 2011)
suggests the domain has an important role in focal adhesion biology.
First described in focal adhesion kinase (FAK) (Arold et al., 2002;
Hayashi et al., 2002), the compact four-helix bundle FAT domain
was subsequently identified in the Cas-family of proteins (Arold
et al., 2002; Garron et al., 2009; Mace et al., 2011), in the focal
adhesion protein vinculin (Arold et al., 2002), in G protein-coupled
receptor kinase-interacting protein ArfGAP 1 (GIT1)
(Schmalzigaug et al., 2007) and more recently in cerebral cavernous
malformation protein 3 (CCM3) (Li et al., 2010). The FAT domain
mediates FAK interaction with paxillin (Hayashi et al., 2002;
Hoellerer et al., 2003), FAK intra-molecular interactions (Brami-
Cherrier et al., 2014), CCM3 interaction with CCM2 (Draheim et al.,
2015), and interactions between the Cas-family proteins and members
of the SH2-containing protein (NSP) family – NSP1, NSP2 (also
known as AND-34 and BCAR3) and NSP3 (also known as SHEP1
and CHAT) (Garron et al., 2009; Mace et al., 2011).
Contrasting with the primarily pro-migratory function ascribed to
p130Cas (Tikhmyanova et al., 2010), NEDD9 function in cell
migration is context specific; in some cell backgrounds, NEDD9 is
pro-migratory (Ohashi et al., 1998; van Seventer et al., 2001; Kim
et al., 2006; Natarajan et al., 2006; Bui et al., 2009; Izumchenko
et al., 2009; Lucas et al., 2010; Kong et al., 2011), in others, NEDD9
restrains cell migration (Simpson et al., 2008; Seo et al., 2011;
Zhong et al., 2012). This divergent function suggests that NEDD9
may tune the focal adhesion response depending on the tissue and
cellular context. Notably, NEDD9 is expressed in a restricted
repertoire of tissues relative to p130Cas (O’Neill et al., 2000), which
is ubiquitously expressed, pointing to a probable tissue-specific
function for NEDD9. In mouse embryo fibroblasts (MEFs),
phosphorylation slows NEDD9 molecular exchange at focal
adhesions, reduces focal adhesion dynamics and, hence,
decelerates cell migration (Baquiran et al., 2013; Bradbury et al.,
2014). Phosphorylation-mediated interactions with other molecules
that are resident at the focal adhesions stabilise NEDD9 interactions
at the focal adhesions (Bradbury et al., 2014).
NEDD9 and p130Cas have a conserved protein–protein
interaction domain structure (O’Neill et al., 2000), comprising an
N-terminal SH3 domain, followed by a substrate binding domain
(SD) with multiple consensus tyrosine phosphorylation sites. A
serine-rich region follows the SD, and lastly the FAT domain, also
known as the Cas-family C-terminal homology (CCH) domain
(Donato et al., 2010). The NEDD9 sequence also encompasses a
protease cleavage site, DLVD, that when cleaved releases an N-
terminal 55 kDa peptide (Law et al., 1998). The N-terminal SH3
and C-terminal FAT domains of NEDD9 and p130Cas each
contribute to focal adhesion targeting (Harte et al., 1996; Nakamoto
et al., 1997; O’Neill and Golemis, 2001; Donato et al., 2010;
Bradbury et al., 2014). Upstream of the FAT domain, both proteinsReceived 24 May 2016; Accepted 2 February 2017
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contain a consensus binding site for Src-family kinases (O’Neill
et al., 2000). FAK phosphorylates the Src-binding site leading to Src
docking (Ruest et al., 2001). Subsequently, Src phosphorylates
tyrosine residues in the SD, creating binding sites for downstream
mediators, such as the adaptor protein Crk. Phosphorylation is
regulated by integrin receptor ligation and focal adhesion formation,
and this reduces NEDD9 cleavage at the DLVD site (O’Neill and
Golemis, 2001). Previous studies have shown that p130Cas is a
mechanosensor at focal adhesions given that force applied to the
p130Cas SD leads to increased phosphorylation (Sawada et al.,
2006; Mui et al., 2015). This stretch activation requires tethering at
either end of the p130Cas SD. While the N-terminal SH3 domain
has been implicated in p130Cas mechanosensing (Janoštiak et al.,
2014b), the requirement for the FAT domain is unknown. As the
FAT domain is an important molecular tether at focal adhesions, it
may also play a role in mechanosensing.
In the present study, we sought to understand the role of the FAT
domain in Cas-family proteins by analysing fusion proteins in
which the NEDD9 FAT domain was exchanged for the homologous
p130Cas FAT domain. Our data reveal that the p130Cas FAT
domain confers a mechanosensory function; evidenced by an
inversion of the relationship between substrate rigidity and cell
speed compared to that of cells expressing wild-type NEDD9.
RESULTS
Exchanging the NEDD9 FAT domain
The NEDD9 C-terminal domain, originating at residue 695,
constitutes the minimal FAT domain (Garron et al., 2009)
(Fig. 1A). Reports that the C-terminal FAT domains of p130Cas
and NEDD9 show high sequence similarity (Arold et al., 2002;
Singh et al., 2008; Garron et al., 2009; Mace et al., 2011) were
confirmed by comparison of orthologous NEDD9 and p130Cas
FAT domains from human, mouse, rat and chicken. Sequence
alignments indicate a high level of conservation (Fig. 1B), with
amino acid residues coloured in orange/red tones indicating the
highest sequence conservation (note that the corresponding FAT
domain in human p130Cas begins at residue 731). As the NEDD9
FAT domain induces cell rounding and apoptosis when expressed in
isolation (O’Neill and Golemis, 2001), it is not possible to compare
NEDD9 and p130Cas FAT domain function in cell migration
through analysis of the discrete FAT domains as peptides.
Therefore, we created an expression construct in which the
NEDD9 FAT domain was exchanged for the p130Cas FAT
domain (Fig. 2A; NEDD9::CasFAT). Note that the difference in
p130Cas amino acid residue numbering in Fig. 2A versus those
shown in Fig. 1B, reflects that the sequence used to create the
NEDD9::CasFAT fusion was derived from the rat p130Cas
sequence as opposed to the human sequence indicated in
Fig. 1A. The resulting NEDD9::CasFAT construct retains the
upstream wild-type NEDD9 sequence, including the Src kinase-
binding motif (DYDY) and the DLVD cleavage site. GFP-tagged
NEDD9 wild-type and NEDD9::CasFAT fusion proteins were
expressed in A172 glioblastoma cells engineered to express
tetracycline-inducible shRNA targeting NEDD9. The fusion
protein expression constructs carried mutations in the NEDD9
shRNA-targeting sequence to allow expression following depletion
of endogenous NEDD9. As shown, tetracycline addition efficiently
depleted the endogenous NEDD9 protein doublet (Fig. 2B, long
exposure). Further, the NEDD9 wild type and NEDD9::CasFAT
rescue constructs were expressed in the presence of tetracycline
(Fig. 2B,C). Both fusion proteins displayed the expected NEDD9
doublet, corresponding to the endogenous protein phosphorylated
forms (Law et al., 1998). We further determined that neither
NEDD9 depletion (Fig. 2D) nor exogenous protein expression
(Fig. 2E) altered endogenous levels of the interacting partner protein
FAK or p130Cas. Quantification by performing densitometry
confirmed that there were no significant changes to FAK or
p130Cas expression (Fig. 2F).
CasFAT retains focal adhesion targeting information but
slows molecular exchange
The FAT domain is required to target NEDD9 to focal adhesions
(O’Neill and Golemis, 2001; Bradbury et al., 2014); therefore, we
investigated whether CasFAT was competent to target the fusion
protein to focal adhesions. Immunofluorescence analysis revealed
that CasFAT indeed substitutes for the NEDD9 FAT domain in
targeting the molecule to focal adhesions (Fig. 3A). Comparison of
the morphology of paxillin-positive focal adhesions showed that
cells expressing GFP-tagged wild-type NEDD9 and NEDD9::
CasFAT had the same number and size of focal adhesions (Fig. 3B).
The size of individual focal adhesions was also unchanged (GFP–
NEDD9=12.2 pixel±0.5; GFP–NEDD9::CasFAT=12.2 pixel±0.6;
mean±s.e.m.; not significant, Student’s t-test). Thus, focal adhesion
morphologies were unaffected by the CasFAT substitution. Since
NEDD9 constructs lacking the FAT domain show rapid molecular
exchange at focal adhesions when compared with full length
Fig. 1. NEDD9 domain structure and p130Cas protein FAT domain
alignment. (A) Schematic representation of the NEDD9 protein sequence
showing the N-terminal SH3 domain, followed by the SH2-binding domain
(SH2BD), serine-rich region (SRR) and the C-terminal domain (CT) containing
the Src kinase-binding site (DYDY). Also shown is the cleavage site (DLVD);
post-translational cleavage at this site generates a 55 kDa N-terminal peptide.
The extracted region indicates the position of the focal adhesion-targeting
(FAT) domain comprising residues 695-834 in the CT. (B) NEDD9 and
p130Cas FAT (CasFAT) domains aligned using the PRALINE website. Amino
acid residue numbers for human NEDD9 and p130Cas are shown. Sequences
correspond to human (h), mouse (m), rat (r) and chicken (c). Colours indicate
sequence conservation, with red indicating the most conserved alignment
position and blue denoting the least conserved alignment position.
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NEDD9 (Bradbury et al., 2014), we determined the effect of the
FAT domain on the rates of protein exchange. Fluorescence
recovery after photobleaching (FRAP) analysis of GFP-positive
focal adhesions revealed that GFP–NEDD9::CasFAT fluorescence
was significantly slower to recover than that of the wild-type
NEDD9 molecule (Fig. 3C-E).
CasFAT specifically inhibits cell migration
Next, we questioned the effects on cell speed. Previous
demonstrations of cell-type-specific effects (Ohashi et al., 1998;
van Seventer et al., 2001; Kim et al., 2006; Natarajan et al., 2006;
Simpson et al., 2008; Bui et al., 2009; Izumchenko et al., 2009;
Lucas et al., 2010; Kong et al., 2011; Seo et al., 2011; Zhong
et al., 2012) first necessitated the assessment of NEDD9
expression and the regulation of A172 cell speeds. Time-lapse
imaging, tracking and quantification of the mean squared
displacement (MSD) revealed that NEDD9 depletion
significantly increased A172 two-dimensional (2D) migration
speeds (Fig. 4A,B). Exogenous expression of the NEDD9 rescue
construct returned migration speeds to those seen under control
conditions, confirming that the effect was NEDD9-dependent
(Fig. 4A,B). These findings parallel earlier data showing
increased 2D migration speeds of NEDD9-knockout MEFs
(Zhong et al., 2012). Previously, we have shown that NEDD9-
knockout MEFs exhibit increased surface expression of the
fibronectin receptor integrin α5β1 (Zhong et al., 2012). However,
analysis of A172 adhesion to fibronectin, and to other
extracellular matrix components, revealed no difference in
adhesion following NEDD9 depletion (Fig. 4C).
Correspondingly, the surface expression of integrin α5β1 was
unchanged following NEDD9 depletion in the A172 cells
(Fig. 4C, inset); thus, this effect may be cell-type specific.
Previous studies have reported that loss of FAK or p130Cas from
focal adhesions decreases intracellular stiffness (Bae et al., 2014;
Janoštiak et al., 2014b). Consequently, we assessed membrane
compliance by performing AFM; however, there was no
significant difference in Young’s modulus between control cells
and NEDD9-depleted cells (Fig. 4D). Collectively, these data
reveal that NEDD9 restrains 2D migration of A172 cells but that
this is not due to changes in adhesion or cell compliance.
We next questioned the effect of CasFAT on cell speed.
Strikingly, NEDD9::CasFAT-expressing cells were significantly
Fig. 2. Tetracycline-inducible NEDD9 knockdown and FAT domain fusion protein expression. (A) Schematic representation of the NEDD9 p130Cas FAT
domain exchange construct. The FAT domain of NEDD9 (residues 695-834) was replaced with p130Cas residues 789-968 to generate NEDD9::CasFAT.
(B) Western blot analysis of whole cell lysates of control cells (Tet−) or following NEDD9 depletion (Tet+) that had been transfected with GFP vector control or the
GFP-tagged NEDD9 rescue construct. Note the doublets of NEDD9 protein corresponding to the 105 kDa and 115 kDaNEDD9 phosphorylated forms (Bradshaw
et al., 2011) fused to GFP. Two different autoradiograph exposures are shown to reveal the doublet of the GFP-tagged NEDD9 protein (short exposure) and
endogenous NEDD9 (long exposure). (C) Western blots showing exogenous GFP-tagged wild-type NEDD9 and NEDD9::CasFAT expression following
endogenous NEDD9 depletion. Note that the images shown are from an exposure following antibody probing for both NEDD9 and HSP70. The same blot is
reshown in Fig. 7C. (D) Endogenous p130Cas, FAK andSrc expression under control conditions and followingNEDD9 depletion (+Tetracycline). (E) Endogenous
p130Cas and FAK expression following exogenous expression of GFP–NEDD9 and GFP–NEDD9::CasFAT in the presence of tetracycline to deplete
endogenous NEDD9. Note that the p130Cas antibody-binding epitope is conserved in the sequence of NEDD9 and is located upstream of the FAT domain (Law
et al., 1998), therefore p130Cas antibodies detect both endogenous p130Cas and the exogenously expressed GFP fusion proteins. HSP70 expression is shown
for all blots to indicate protein loading. (F) Histograms showing densitometry measurements of the levels of p130Cas and FAK expressed relative to those of
HSP70 in cells that had been transfected with the indicated constructs. Data represent the average of triplicate repeats on separate days and error bars show the s.
e.m. NS, not significant; Student’s t-test.
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slower than cells under all other conditions tested (Fig. 5A). In fact,
the majority of NEDD9::CasFAT cells were non-motile (Fig. 5B).
To determine whether the effects on cell speed are specific to the
expression of CasFAT, we analysed an alternative chimeric protein
in which the NEDD9 FAT domain was substituted with the FAT
domain of FAK (NEDD9::FAKFAT). Importantly, this chimeric
protein also targeted to focal adhesions (Fig. 5C,D). FRAP analysis
of NEDD9::FAKFAT revealed that the FAK FAT domain
significantly slowed molecular exchange at focal adhesions
(Fig. 5E), similar to the results seen with the NEDD9::CasFAT
protein. But in contrast to NEDD9::CasFAT-expressing cells, cells
expressing NEDD9::FAKFAT migrated with the same speed as
wild-type NEDD9-expressing cells and significantly faster than
NEDD9::CasFAT-expressing cells (Fig. 5A). This indicates that the
slowing of cell migration speed through expression of the NEDD9::
CasFAT molecule is not simply a result of slowed molecular
exchange at the focal adhesions. We tested whether the slowed
migration speeds correlated with increased adhesive force, thereby
anchoring cells and preventing migration. Using a magnetic tweezer
device, we analysed cell adhesion force to fibronectin-coated
magnetic beads exposed to increasing lateral pulling force in the
range of 0 to 40 nN. This revealed no significant difference in
adhesive force between control cells and NEDD9-depleted cells
versus the cells expressing GFP–NEDD9::CasFAT (Fig. 5F).
Therefore, CasFAT arrests cell migration but does not change the
adhesive force.
Fig. 3. CasFAT slows dynamic exchange at focal adhesions. (A) Confocal images of control cells (Tet−) or following NEDD9 depletion (Tet+) and transfection
with GFP vector control, GFP–NEDD9 or GFP–NEDD9::CasFAT, as indicated. Shown are single confocal slices for GFP, paxillin and merged images. Scale
bars: 20 µm. (B) Themean number of paxillin-positive focal adhesions per cell (top graph) and the paxillin-positive focal adhesion area expressed as a percentage
of the total cell area (bottom graph) in cells expressing GFP–NEDD9 andGFP–NEDD9::CasFAT, as indicated. Data points represent the mean value for each cell
(≥17 transfected cells examined per construct). NS, not significant; Student’s t-test. (C) Representative images of focal adhesions before photobleaching
(first panels), immediately post bleaching (0", 0 s) and throughout fluorescence recovery (5–60″). Scale bars: 5 µm. (D) Recovery kinetics of GFP–NEDD9 (black
squares) and GFP–NEDD9::CasFAT (grey squares). Data show normalised average fluorescence recovery over the 90 s recovery period. (E) Mean fluorescence
recovery rate under the indicated conditions. ****P>0.0001; Student’s t-test. Data represent pooled means of n≥4 independent experiments (≥49 total focal
adhesions analysed per construct). Data are mean±s.e.m.
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Matrix rigidity enhances CasFAT-mediated inhibition of
migration
Based on previous observations that p130Cas is a
mechanotransducing protein (Sawada et al., 2006; Mui et al.,
2015), we questioned whether the CasFAT confers sensitivity to
rigidity. To address this, we analysed migration on soft fibronectin-
coated polyacrylamide (PAM) hydrogels of 0.2 kPa and 1.0 kPa.
Cells expressing either GFP–NEDD9 or GFP–NEDD9::CasFAT
exhibited a rounded appearance on the softest gels and a more
elongated appearance on 1.0 kPa gels (Fig. 6A). NEDD9 depletion
caused cells to move faster than control cells, both on the 0.2 kPa
and 1.0 kPa gels, as well as on the plastic dishes (Fig. 6B).
Importantly, exogenous NEDD9 expression reversed the effects of
NEDD9 depletion (Fig. 6B). Contrasting this rigidity-dependent
induction of speed, cells expressing the NEDD9::CasFAT construct
moved fastest on the 0.2 kPa gels, while migration was significantly
inhibited on the 1.0 kPa gels and plastic surface (Fig. 6B).
Paralleling this finding, the percentage of motile NEDD9::
CasFAT cells significantly decreased with increasing substrate
rigidity, but cells expressing wild-type NEDD9 were unaffected
(Fig. 6C). The rigidity-dependent effect appears to be specific to
CasFAT as cells expressing NEDD9::FAKFAT did not slow with
increased rigidity and instead exhibited the same response as cells
expressing NEDD9 (Fig. 6B). Importantly, there was no difference
in polarity between cells expressing either GFP–NEDD9 or GFP–
NEDD9::CasFAT when compared between cells grown on
substrates of the same rigidity (Fig. 6D). Furthermore, there was
no difference in the directional persistence (ratio of the vectorial
distance traveled to the total path length described by the cell)
between cells expressing GFP–NEDD9 versus those expressing
GFP–NEDD9::CasFAT (ratio values of 0.3±0.015 versus 0.30±
0.017; mean±s.e.m.; not significant, Student’s t-test) during
migration on plastic. Therefore, these data suggest that CasFAT-
mediated reductions in cell migration are unlikely to be due to
altered polarity. Collectively, these data suggest that CasFAT plays
an important role in sensing external mechanical force.
CasFAT induces rigidity-dependent NEDD9 phosphorylation
and inhibits cleavage
The application of external force to p130Cas stretches the
molecule and activates its signalling function through enhanced
phosphorylation of the substrate-binding domain (Sawada et al.,
2006). We therefore next assessed if CasFAT increased NEDD9
tyrosine phosphorylation. Our analyses confirmed that
phosphorylation of tyrosine residues within NEDD9::CasFAT was
1.7-fold greater than that of the wild-type NEDD9 protein (Fig. 7A).
Expression levels of NEDD9::CasFAT were consistently low,
which agrees with previous demonstrations that phosphorylation of
Fig. 4. Exogenous NEDD9 rescues the faster migration induced by NEDD9 knockdown. (A) MSD calculated from trajectories of control cells (−Tet)
transfected with GFP vector (white triangles); following endogenous NEDD9 depletion (+Tet) and transfection with GFP vector (black squares); and following
endogenous NEDD9 depletion and expressing GFP–NEDD9 (black triangles). (B) Speeds of individual cells grown under the conditions described in A. Data
represent pooled means of n≥155 total cells analysed per construct. ****P<0.0001, one-way ANOVAwith Tukey’s multiple comparison post-test. (C) Adhesion to
the indicated matrices was measured in control cells (−Tet) and following NEDD9 depletion (+Tet). No statistical difference in adhesion to any matrix was seen
between either condition; NS, not significant; Student’s t-test. Data represent pooled averages of three independent experiments. Inset graph shows surface
expression [mean fluorescence intensity (MFI) of α5β1 integrin receptor by FACs analysis]. NS, not significant; Student’s t-test. (D) AFM height maps of a control
A172 cell (left) and following NEDD9 knockdown (Tet+, right image) were generated for measurements of Young’s moduli. Bar plot shows mean±s.e.m. of n>11
individual cells from three separate experiments analysed per condition, with 4–16 measurements performed per cell. NS, not significant; Student’s t-test. Data
shown are mean±s.e.m.
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NEDD9 regulates its proteasomal degradation (Liu et al., 2000).
Treatment with the phosphatase inhibitor Na3VO4 thus further
depletes total NEDD9::CasFAT. Despite low total NEDD9::
CasFAT expression, the ratio of phosphorylated protein to total
protein was significantly higher in the NEDD9::CasFAT-expressing
cells (Fig. 7A). To determine whether tyrosine phosphorylation is
rigidity dependent, phosphorylation was compared between cells
grown on fibronectin-coated plastic versus fibronectin-coated
0.2 kPa gels (Fig. 7B). This revealed that phosphorylation
increased with substrate rigidity (Fig. 7B).
NEDD9 phosphorylation has been reported to regulate the
cleavage of the full-length NEDD9 protein, with de-phosphorylated
NEDD9 cleaved to generate a 55 kDa N-terminal peptide (O’Neill
and Golemis, 2001). Accordingly, there was significantly less
cleavage product generated from the NEDD9::CasFAT protein
versus wild-type NEDD9 (Fig. 7C). Moreover, stimulating
increased tyrosine phosphorylation through pre-treatment with the
phosphatase inhibitor Na3VO4 reduces cleavage of both wild-type
NEDD9 and NEDD9::FAKFAT (Fig. 7D). The role of cleavage in
regulating cell migration was next tested by analysing cells that had
been transfected with a NEDD9 expression construct in which the
previously characterised DLVD cleavage site (Law et al., 1998,
2000) had been mutated to the sequence DLVA (NEDD9-DVLA),
which abrogates the cleavage (Fig. 7E). As the NEDD9-DLVA
mutant construct does not carry the mutations to prevent NEDD9
targeting by shRNA, analysis of this mutant was performed in
NEDD9−/− MEFs (Zhong et al., 2012). Providing independent
confirmation of the role of CasFAT in A172 cells, expression of
GFP–NEDD9::CasFAT also significantly reduced the speed of
NEDD9−/− MEFs compared to that upon expression of wild-type
NEDD9 (Fig. 7F). Moreover, cells expressing the NEDD9-DLVA
mutant protein also migrated significantly more slowly (Fig. 7F). In
summary, the data suggest that NEDD9 cleavage is an important
determinant of cell migration and, further, that CasFAT inhibits
cleavage by inducing tyrosine phosphorylation.
DISCUSSION
Numerous adhesion proteins express FAT domains, yet the role
and function of the FAT domain remains poorly understood. In
the present study, we show that the Cas-family FAT domains
have both overlapping and distinct functions. Our data suggest
that the FAT domain of p130Cas (referred to here as CasFAT)
uniquely determines the mechanosensing function. The
substitution of the CasFAT domain for the endogenous FAT
Fig. 5. Comparison of CasFAT and FAKFAT domain effects. (A) Speeds of individual A172 cells following depletion of endogenous NEDD9 and transfection
with the indicated constructs. Note that the GFP–NEDD9 data are the same as that shown in Fig. 4B, replicated here for comparison. ****P<0.0001 compared to
GFP–NEDD9, Student’s t-test. n≥163 total cells analysed per construct. (B) The percentage of motile cells under the indicated conditions. Data represent pooled
means of n≥4 independent experiments (≥163 individual cells analysed per construct). ****P<0.0001, Student’s t-test. (C)Western blot showing expression of the
GFP–NEDD9::FAKFAT chimeric protein. (D) Confocal images of cells following NEDD9 depletion (Tet+) and transfection with GFP–NEDD9::FAKFAT. Shown
are single confocal slices for GFP, paxillin and merged images. Scale bar: 20 µm. (E) Mean fluorescent recovery rate of GFP–NEDD9::FAKFAT under the
indicated conditions. ****P>0.0001, Student’s t-test. Data represent pooled means of n≥4 independent experiments (≥49 total focal adhesions analysed per
construct). Note that the GFP–NEDD9 data is the same as that shown in Fig. 3E, replicated here for comparison. (F) Measurement of force at which fibronectin-
coated magnetic beads could be detached from the cell surface following application of a linearly increasing force with a magnetic tweezer device. Circles
represent individual cell measurements. NS, not significant, one-way ANOVA. Data shown are mean±s.e.m.
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domain of NEDD9 resulted in high level phosphorylation of
NEDD9, reduced cleavage and proportionally reduced cell
migration speeds. Our study illustrates how otherwise
structurally homologous protein domains can confer opposite
cellular functions.
While a mechanosensing role for NEDD9 has been inferred
in the past based on sequence and functional homology with
p130Cas, to date this has not been experimentally validated. In
the present study, we have analysed the consequence of NEDD9
expression for cell migration in response to substrates with a
range of rigidities. We found increasing cell speed in response to
more rigid substrates. Interestingly, NEDD9 depletion resulted in
∼1.5-fold higher speeds overall, regardless of substrate rigidity.
Collectively, these data suggest that, unlike p130Cas, NEDD9
may not have a mechanosensory function, at least in terms of
regulating cell migration. In contrast, cells expressing NEDD9::
CasFAT displayed an inverse relationship between substrate
rigidity and cell speed, with the fastest cell speeds seen on the
softest gels. Thus, in addition to previous data suggesting that the
SH3 domain confers a mechanosensory function (Janoštiak et al.,
2014b), our data suggest an important role for CasFAT in
mechanosensing.
Rigidity-mediated activation of p130Cas leads to
phosphorylation of the p130Cas SD (Sawada et al., 2006), and
our data reveal that substitution of the p130Cas FAT domain for that
of NEDD9 similarly induces NEDD9 phosphorylation. The
p130Cas Src-binding site diverges from the NEDD9 site as it is a
bipartite binding motif, consisting of a polyproline Src SH3-binding
domain juxtaposed to the Src SH2-binding domain (O’Neill et al.,
2000). Although it has previously been shown that the p130Cas
polyproline domain is required in order for Src to induce colony
formation in soft agar when co-transfected with p130Cas (Huang
et al., 2002), our data indicate that the polyproline domain may
not be required for the p130Cas mechanosensing function.
Interestingly, structural analysis of CasFAT suggests that it
mediates tight binding to the interacting partner NSP3 by virtue
of the bipartite binding motif (Mace et al., 2011).
We have previously shown that phosphorylation of the
NEDD9 SD is a critical determinant of the rate of NEDD9
exchange at focal adhesions (Bradbury et al., 2014) and,
Fig. 6. Rigidity-dependent cell speed. (A) Confocal images of cells expressing the indicated GFP-tagged constructs, plated on fibronectin-coated
polyacrylamide hydrogels of 0.2 kPa (top panels) and 1 kPa (bottom panels). Images show GFP (green), phalloidin staining of F-actin (red) and merged images.
Scale bar: 20 µm. (B) Average speeds of control cells (Tet−) or following NEDD9 depletion (Tet+) and transfected with the indicated constructs. Cells were
cultured on polyacrylamide hydrogels of 0.2 kPa (black bars), 1.0 kPa (grey bars) or plastic (white bars). Note that the cell speeds for plastic surfaces are the same
as those represented in Fig. 5A, data are now plotted as a column graph. Error bars represent s.e.m. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001, one-way
ANOVA with Tukey’s multiple comparisons post-test. Data represent pooled means of n≥4 independent experiments (≥155 total cells analysed per construct).
(C) Percentage of motile cells under the indicated conditions. Error bars represent s.e.m. ***P<0.001, ****P<0.0001, one-way ANOVA with Tukey’s multiple
comparisons post-test. Data represent pooled means of n≥4 independent experiments (≥155 total cells analysed per construct). (D) Cell polarity [longest chord
through the cell (length) divided by the widest length (width) perpendicular to the longest chord]. Data represent pooled means of n≥4 independent experiments
(≥155 total cells analysed per construct). *P>0.05, one-way ANOVAwith Tukey’s multiple comparisons post-test. There was no significant difference in polarity
between transfectants grown on matching substrates.
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congruent with this finding, the CasFAT-containing NEDD9
protein with high levels of phosphorylation has significantly
slower exchange rates at the focal adhesions. Phosphorylation of
the p130Cas substrate domain conversely accelerates p130Cas
displacement from focal adhesions and increases cell migration
speed (Meenderink et al., 2010; Machiyama et al., 2014). Thus,
these two highly related proteins employ the same mechanism –
phosphorylation of the SD – to deliver opposite functional
outcomes. It is notable that mutation of a single tyrosine residue
that is conserved between NEDD9 and p130Cas and that forms a
consensus binding site for the adaptor protein Crk also has
opposite effects on cell migration outcomes (Baquiran et al.,
2013). Previous studies have revealed that NEDD9 is post-
translationally cleaved, releasing a 55 kDa N-terminal protein,
and that this is regulated by phosphorylation (Law et al., 1998;
O’Neill and Golemis, 2001). Data in the present study confirm
that increased phosphorylation reduces cleavage and that
abrogating cleavage inhibits cell migration.
Collectively, the data presented in this study highlight a specific
role for the FAT domain of p130Cas in mechanosensing. Although
FAK and vinculin are known to be involved in mechanosensing and
mechanotransduction (Janoštiak et al., 2014a; Goldmann, 2016),
the specific roles of their FAT domains in this process is unknown.
Notably, our study reveals that, unlike CasFAT, the FAT domain of
FAK does not change migration speed. In future, it will be
interesting to analyse the role of FAT domains in the
mechanosensing and mechanotransduction properties of other
proteins containing such domains.
MATERIALS AND METHODS
Sequence alignments
Sequence alignment of FAT domains, based on previously described
structural analyses (Arold et al., 2002; Garron et al., 2009), was performed
using PRALINE (http://www.ibi.vu.nl/programs/pralinewww) (Simossis
and Heringa, 2005). The following sequences were compared: NEDD9
Homo sapiens (Q14511-1), Mus musculus (NM_017464), Rattus
norvegicus (NM_001011922), Gallus gallus (XM_418946); p130Cas
Homo sapiens (P56941-1), Mus musculus (NM_009954), Rattus
norvegicus (NM_012931), Gallus gallus (XM_414057).
cDNA expression constructs
The plasmids used include previously described expression constructs for
GFP and GFP-tagged human NEDD9 (O’Neill and Golemis, 2001) and
Fig. 7. Rigidity-dependent regulation of phosphorylation, cleavage andmigration. (A) Western blot showing phosphorylation of tyrosine (p-Tyr) residues on
exogenously expressed GFP–NEDD9 and GFP–NEDD::CasFAT. Histogram underneath shows the levels of tyrosine phosphorylation expressed relative to the
total GFP-tagged protein. **P<0.01, Student’s t-test. (B) Comparison of tyrosine phosphorylation of exogenous proteins extracted from cells grown on fibronectin-
coated plastic versus fibronectin-coated 0.2 kPa gels. All cells were pre-treated with the tyrosine phosphatase inhibitor Na3V04. Shown are the GFP-tagged full-
length proteins and phosphorylated-tyrosine levels of the full length molecules. Blots were stripped subsequent to anti-phosphorylated-tyrosine analysis and then
re-probed with anti-NEDD9 antibodies. (C) Expression of GFP-tagged full length proteins and the p55 NEDD9 N-terminal cleavage product (Fig. 1A shows
location of the DLVD cleavage site). Note that the blots showing theNEDD9 cleavage product are the same as those in Fig. 2C but prior to HSP70 immunoblotting.
Controls are from the subsequent HSP70 reprobe of the blot that is shown in Fig. 2C. The histogram underneath shows densitometry quantification of the
percentage of cleavage [(p55/full length+p55)×100]. Analysis was performed on three independent biological replicates; *P<0.05, Student’s t-test. (D) Western
blots of lysates from cells expressing the indicated exogenous proteins (all GFP tagged). Cells were treated under control conditions or with the phosphatase
inhibitor Na3VO4 as indicated. Expression of the NEDD9 p55 cleavage product is indicated. (E) Mutation of the DLVD cleavage site (position indicated in Fig. 1A)
to DLVA abrogates production of the 55 kDa cleavage product. Western blot shows expression of the indicated exogenous GFP-tagged proteins expressed in
NEDD9−/−MEFs. (F) Speeds of individual NEDD9−/−MEFs transfected with the indicated GFP-tagged expression constructs. ****P<0.0001, one-way ANOVA
with Tukey’s post-comparison test. Data shown are mean±s.e.m.
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GFP-tagged rat p130Cas. The GFP-tagged NEDD9 expression construct in
which the NEDD9 FAT domain was exchanged for the p130Cas FAT
domain was generated using overlap-extension PCR. The following primers
were used to generate a NEDD9 sequence with the FAT domain deleted:
forward, 5′-GGGGCGGGGGGAATTCATGAAGTATAAGAATCTT-3′;
reverse, 5′-CAGTTGACTTTTTCCCTGGGGTAGGCTCTG-3′. The
p130Cas FAT domain: forward, 5′-CAGAGCCTACCCCAGGGAAAAA-
GTCAACTG-3′; reverse, 5′-ATTTCTCGAGTCATG CTGCTGCAAGT-
TGTCC-3′. The two products were subsequently mixed and a new cDNA
generated using the first forward primer and the final reverse primer. The
resulting product was digested with EcoR1–Xho1 and ligated with a
similarly digested GFP-C4 vector DNA, creating the in-frame GFP–
NEDD9::CasFAT expression construct. The same procedure was used to
generate the GFP–NEDD9::FAKFAT construct, with the exception of the
specific primer sequences. To generate a NEDD9 sequence with the FAT
domain deleted, the same forward primer was used but the reverse primer
sequence was 5′-ACTAATTTCTTGGGGTTGGGGTAGGCTCTG-3′. The
FAK FAT domain was generated using the following primers: forward,
5′-CTACCCCAACCCCAAGAAATTAGTCCACCT-3′; reverse, 5′-
ATTTCTCGAGTCAGTGGGGTCTTGTTTGTCCAAG-3′. All constructs
were confirmed by DNA sequencing. NEDD9 shRNA-resistant cDNA
expression constructs were generated by mutation of the shRNA recognition
sequence (four silent point mutations at nucleotides 1536 (C to A), 1539 (G
to C), 1542 (T to C) and 1545 (C to T). Sequence mutagenesis was
performed by GenScript (NJ, USA), and all sequences were independently
verified by DNA sequencing.
Antibodies
Primary antibodies used in the study [dilutions for western blot (WB) and
immunofluorescence (IF) indicated in brackets] include antibodies to
paxillin (clone 349; 610051) (IF: 1/1000 dilution) and p130Cas (clone 21;
610271) (WB: 1/1000 dilution) from BD Transduction Labs; FAK (clone
D2R2E; 13009) (WB: 1:1000) and NEDD9 (clone 2G9; 4044) (WB:
1:1000) (Cell Signaling Technologies; phosphorylated tyrosine (clone
4G10; 05-321) (WB: 1:500) from Merck-Millipore (Darmstadt, Germany);
HSP-70 (clone BRM-22; H5147) (WB: 1:3000) from Sigma Aldrich
(Missouri, USA). Secondary antibodies used throughout this study were
donkey anti-mouse Cy3, donkey anti-mouse Cy5, donkey anti-rabbit Cy3
from Molecular Probes (Life Technologies); sheep anti-mouse horseradish
peroxidase (HRP)-conjugated and donkey anti-rabbit HRP-conjugated
antibodies from GE Life Sciences.
Cell lines
A172 glioblastoma cells were maintained in Dulbecco’s modified eagle’s
medium (DMEM) supplemented with 10% foetal bovine serum (FBS).
Before generating tetracycline-inducible NEDD9 knockdown A172 cells,
the identity of the cells was independently verified by CellBank Australia.
Inducible knockdown lines were created using the BLOCK-iTTM Inducible
H1 RNAi Entry Vector Kit (Life Technologies) in conjunction with the
BLOCK-iTTM Inducible H1 Lentiviral RNAi System (Life Technologies) as
per the manufacturer’s instructions. An shRNA targeting NEDD9 (NEDD9
shRNA) beginning at nucleotide 1529 (5′-CACCGCTGGTCCCTGAAT-
ATCTTGGCGAACCAAGATATTCAGGGACCAGC-3′) was cloned into
the pLenti4 backbone. Tetracycline-inducible NEDD9 shRNA cells were
selected and maintained in DMEM supplemented with 10% FBS (v/v),
2 μg/ml blasticidin and 200 μg/ml zeocin, and passaged every third day at a
ratio of 1:6. To induce NEDD9 knockdown, 1 μg/ml tetracycline was added
to the medium, and cells were incubated for 72 h at 37°C under 5% CO2.
NEDD9−/− mouse embryo fibroblasts have been previously described
(Zhong et al., 2012).
Protein extraction, immunoblotting and immunofluorescence
Phosphatase inhibitor pre-treatment was achieved by incubating cells with
500 µM of Na3VO4 solution (prepared as described previously, Brown and
Gordon, 1984) for 6 h. Cell monolayers were placed on ice and washed
twice with cold PBS and extracted in the appropriate volume of PTY lysis
buffer [50 mM HEPES (pH 7.5), 50 mM NaCl, 5 mM EDTA, 1% Triton
X-100 (v/v), 50 mM NaF, 10 mM Na4P2O7.10H2O]. Cells were collected
with a cell scraper, and lysates were centrifuged at 15,500 g for 10 min at
4°C to remove non-solubilised proteins. The resulting supernatant was
collected and the cell pellet discarded. Extracted proteins were loaded into
wells of SDS-polyacrylamide gels of the appropriate acrylamide percentage.
Separated proteins were then electro-transferred onto methanol-activated
Immobilon PVDF transfer membrane (0.45 mm; Millipore) using chilled
transfer buffer [0.05 M Tris, 0.04 M glycine, 20% methanol (v/v)]. Bound
HRP-conjugated antibodies were detected using Western Lighting
Chemiluminescence Reagent followed by exposure to X-ray film
(Fujifilm, Australia), developed using an X-ray developer (Konica). For
immunofluorescence, cells grown on glass slides were fixed in a 4% PFA in
PBS solution (w/v) for 10 min and permeabilised [0.2% Triton X-100 (v/v),
0.5% BSA (w/v), PBS] for 15 min, followed by antibody probing and the
addition of DAPI (1:10000) and fluorescently tagged phalloidin. Coverslips
were mounted using FluoroSave (Calbiochem). Cells were imaged using an
inverted confocal microscope (Leica SP5) equipped with a HCV PL APO
CS 63×1.4 oil objective. Cell images were captured using the following
settings: 512×512 pixels at 100 Hz with a line average of 8. For GFP-
expressing cells, the argon laser power was set to 20%with the 488 nm laser
set to an intensity of 20%, the smart gain and offset were set to 1100.0 V and
0.0%, respectively. For cells immunofluorescently labelled with Cy3- and
Cy5-tagged secondary antibodies, the 561 nm and 633 nm lasers were set to
20% with a smart gain of 800 V and 1060 V, respectively, with both
wavelengths having the offset at 0.0%. For nuclei excitation, the 405 nm
laser was again set 20% with the smart gain set to 600 V.
Polyacrylamide hydrogels
Easy-coat polyacrylamide (PAM) hydrogels of a defined Young’s modulus
(E) in 35-mm Petrisoft (plastic bottom) and Softview (glass bottom) cell
culture dish formats were purchased (Matrigen, CA). Petrisoft dishes were
used for brightfield-based assessment of migration and morphology
experiments, and Softview dishes for confocal microscopy. PAM
hydrogels were coated with fibronectin at room temperature for 1 h under
sterile conditions and then used immediately. Cells were seeded onto gels at
densities that yielded single non-touching cells.
AFM and magnetic tweezers
To investigate the mechanical properties of the cells with AFM (MFP-3D,
AsylumResearch,CA), arrays of 20×20 force curves on a20×20 (or10×10)µm
areas were recorded on the sample immersed in medium at 37°C in force
spectroscopy mode. The microscope was mounted on an anti-vibration
table (Herzan, CA) and operated within an acoustic isolation enclosure
(TMC). First, the cells were localised using an integrated optical
microscope. To reduce the influence of the cantilever edge, only regions
of the cell that were at maximum height (furthest from the coverslip) were
considered for analysis. The force curves were recorded using a SiNi
cantilever (Budget Sensors, Bulgaria) having a nominal spring constant
KN=0.06 N/m. Before use, the cantilevers were calibrated against a glass
slide, and with the thermal vibration method. For all the experiments, the
loading force was kept constant at 400 pN (indentation of about 300 nm)
and the velocity at 2 µm/s. The force-indentation curves were analysed
using IGOR software. The Young’s modulus, E, was calculated using the
Oliver–Pharr model. The Young’s modulus determined from AFM
measurements is a relative value and can only be used for comparative
studies in cases when all the experimental conditions are kept the same.
Magnetic tweezer experiments to measure adhesive force to fibronectin-
coated beads was performed as previously described (Zhong et al., 2012).
Adhesion assay
Cell adhesion assays were conducted as per the manufacturer’s instructions
(Cell Biolabs, CA, USA). Briefly, 7.5×104 cells were plated onto
extracellular matrix-coated wells and incubated for 90 min at 37°C under
5% CO2. Medium was then removed and cells were washed with PBS. Cell
Stain Solution was added and incubated for 10 min at room temperature.
The cells were then washed with dH2O and allowed to air dry before the
addition of Extraction Solution; cells were then incubated for 10 min at
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room temperature with orbital shaking. Finally, the extracted samples were
transferred to a 96 well plate and the optical density measured at 560 nm.
Transfections
Transfections were performed using electroporation (Amaxa Nucleofector
II, LONZA, Melbourne, Australia). A172 cells were transfected using the
Cell Line Nucleofector Kit V according to the manufacturer’s instructions.
Briefly, the day before transfection, cells were re-plated to stimulate
exponential growth. The following day, 2×106 cells were collected and
resuspended in Nucleofection Solution, 10 μg of plasmid DNA was added
and the mixture transferred to a glass cuvette. The cuvette was then placed in
the electroporator and transfections carried out using the U-029 preset
program. Following nucleofection, cells were resuspended in complete
culture medium and plated at the indicated densities for further experiments.
Time-lapse imaging and cell tracking
The day prior to imaging, 8×104 cells were seeded into either a single well of
a 6-well plate (Corning) or 35-mm dishes containing PAM hydrogels and
incubated overnight at 37°C under 5% CO2. All dishes were first coated
with 2 μg/cm2 of fibronectin. The following day, complete medium was
replaced with CO2-independent medium and equilibrated for an hour at
37°C. Migration studies were conducted over a 12 h period with frames
taken every 5 min. Cells were imaged using a 20× air objective of an
automated Olympus IX81 inverted microscope controlled by Metamorph
v6.3 software (Molecular Devices) and equipped with a heating chamber
and floating anti-vibration table. GFP-positive cells were first identified in
fluorescent mode and subsequently tracked throughout the time course in
the brightfield view (12 h). Cells undergoing division or apoptosis were
excluded from image analysis. Cell speeds were calculated from theMSD of
the nucleus position versus time. The percentage of moving cells was
determined as previously reported (Grundy et al., 2016).
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